Gorgojo-Martnez JJ, Mezquita-Raya P, Carretero-Gmez J, Castro A, Cebrin-Cuenca A, de Torres-Snchez A, Garca-de-Lucas MD, Nez J, Obaya JC, Soler MJ, Grriz JL, Rubio-Herrera M
Thanks to online GLP-1 prescription services, getting access to these treatments is now more convenient, private, and accessible than ever before
Factors influencing individual results include: Baseline metabolic health and insulin resistance Adherence to dietary and physical activity recommendations Genetic predisposition to weight loss Concurrent medications that may affect weight Psychological factors and eating behaviours Patients should maintain realistic expectations: whilst significant abdominal fat reduction is achievable, GLP-1 therapy will not produce a flat stomach or eliminate all belly fat, particularly in those with substantial weight to lose
In the United Kingdom, the regulation of medicines is overseen by the Medicines and Healthcare products Regulatory Agency (MHRA)
GHK-Cu has no FDA-approved indication
We continue to find new ways to make access to our medicines more convenient, meeting people where they are, a Novo Nordisk spokeswoman said